Which of the following is a mineral bone disease (MBD) medication?

• A. Epogen
• B. Furosemide
• C. Gentamicin
• D. Cinacalcet

Answer: (D)

In dialysis-related mineral bone disorder, medicines that directly control parathyroid hormone and mineral balance are used. Cinacalcet is a calcimimetic that makes the parathyroid glands more sensitive to calcium, which lowers parathyroid hormone (PTH) release. Lower PTH helps reduce bone turnover and helps balance calcium and phosphate, addressing secondary hyperparathyroidism, a core issue in CKD–MBD. That’s why cinacalcet is the mineral bone disease medication. Epogen treats anemia by stimulating red blood cell production, not bone-mineral balance. Furosemide is a diuretic used for fluid management, and Gentamicin is an antibiotic. They do not address mineral bone disease.